The Record header image

Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article

March 2024

Requirements and codes changed for some medical benefit drugs

Blue Cross Blue Shield of Michigan and Blue Care Network encourage proper utilization of high-cost medications that are covered under the medical benefit. As part of this effort, we maintain comprehensive lists of requirements for our members. 

In October, November and December of 2023, we added requirements for some medical benefit drugs. These requirements went into effect on various dates. In addition, some drugs were assigned new HCPCS codes.

Changes in requirements

For Blue Cross commercial and BCN commercial members, we added prior authorization requirements for the following drugs:

HCPCS code

Brand name

Generic name

J3590**

Casgevy™  

Exagamglogene autotemcel

J3590**

Cosentyx® IV

Secukinumab

J3590**

Daxxify®

Daxibotulinum toxina-lanm

J3590**

Entyvio® SQ

Vedolizumab

J3590**

Lyfgenia™

Lovo-cel

J3590**

Omvoh™ IV and SC

Mirikizumab-mrkz

J3590**

Pombiliti™  

Cipaglucosidase alfa-atga

J3590**

Rethymic®

Allogeneic processed thymus tissue–agdc

J3590**

Rivfloza™

Nedosiran - SQ injection

J3590**

Tofidence™

Tocilizumab-bavi - IV injection

J3590**

Wezlana™

Ustekinumab-auub

For Medicare Plus Blue℠ and BCN Advantage℠ members, we added prior authorization requirements for the following drugs:

HCPCS code

Brand name

Generic name

For dates of service on or after

J1745

Generic (non-biosimilar)

Infliximab

Oct. 15, 2023

J3490

Izervay™

Avacincaptad pegol

Oct. 15, 2023

J3490

Eylea® HD

Aflibercept

Oct. 15, 2023

J3590

Lantidra™

Donislecel-jujn

Oct. 15, 2023

J3590

Veopoz™

Pozelimab-bbfg

Oct. 15, 2023

J3490

Daxxify®

DaxibotulinumtoxinA-lanm

Dec. 18, 2023

Code changes

The table below shows HCPCS code changes that were effective Oct. 1, 2023 (unless otherwise noted), for the medical benefit drugs we manage.

New HCPCS code

Brand name

Generic name

C9157

Qalsody®

Tofersen

J0801

Acthar® Gel

Corticotropin

J0802

Purified Cortropin® Gel

Corticotropin

J2781

Syfovre®

Pegcetacoplan injection

Drug lists

For additional details, see the following drug lists:

These lists are also available on the ereferrals.bcbsm.com website at:

Additional information about these requirements

We communicated these changes previously through provider alerts, which contain additional details.
You can view the provider alerts at ereferrals.bcbsm.com and on our Provider Resources site, which is accessible through our provider portal, availity.com.***

Additional information for Blue Cross commercial groups

For Blue Cross commercial groups, authorization requirements apply only to groups that participate in the standard commercial Medical Drug Prior Authorization Program for drugs administered under the medical benefit. To determine whether a group participates in the prior authorization program, see the Specialty Pharmacy Prior Authorization Master Opt-in/out Group list. A link to this list is also available on the Blue Cross Medical Benefit Drugs page of the ereferrals.bcbsm.com website.

Blue Cross and Blue Shield Federal Employee Program® members and UAW Retiree Medical Benefits Trust (non-Medicare) members don't participate in the standard prior authorization program.

Reminder: An authorization approval isn’t a guarantee of payment. Health care providers need to verify eligibility and benefits for members.

 

**May be assigned a unique code in the future.

***Blue Cross Blue Shield of Michigan doesn’t own or control this website.

Availity® is an independent company that contracts with Blue Cross Blue Shield of Michigan and Blue Care Network to offer provider portal and electronic data interchange services.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2023 American Medical Association. All rights reserved.